|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 317/30 | |
| C07D 405/04 | |||
| C07D 411/04 | |||
| C07D 307/20 | |||
| C07D 307/33 | |||
| C07H 15/203 | |||
| C07H 19/06 |
| (11) | Number of the document | 1809301 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05808357.7 |
| Date of filing the European patent application | 2005-09-13 | |
| (97) | Date of publication of the European application | 2007-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/032406 |
| Date | 2005-09-13 |
| (87) | Number | WO 2006/031725 |
| Date | 2006-03-23 |
| (30) | Number | Date | Country code |
| 609783 P | 2004-09-14 | US | |
| 610035 P | 2004-09-15 | US | |
| 666230 P | 2005-03-29 | US |
| (72) |
CHUN, Byoung-Kwon, US
WANG, Peiyuan, US
DU, Jinfa, US
RACHAKONDA, Suguna, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | 2-FLUORO-2-ALKYL-SUBSTITUTED D-RIBONOLACTONE INTERMEDIATES |
| 2-FLUORO-2-ALKYL-SUBSTITUTED D-RIBONOLACTONE INTERMEDIATES |